Sort
16,300 grants matching “fatty liver disease”
Role of Peripheral Insulin Resistance and Inflammation in Alzheimerâs Disease
$738,843Jason K Kim · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AG
Southern California Children's Enviromental Health Center (SC-CEHC)
$738,324Rob S McConnell · University Of Southern California · P01 · FY2014 · ES
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity
$738,293Jonathan C Cohen · Ut Southwestern Medical Center · RL1 · FY2010 · HL
Fatty liver disease and its determinants in an American Indian Population: the Strong Heart Study
$737,991Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2018 · DK
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$737,386Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2017 · CA
Regulation and Requirements for Coenzyme A Biosynthesis
$737,034Christian Dibble · Beth Israel Deaconess Medical Center · R01 · FY2025 · DK
Genetic Architecture of Adiposity in Multiple Large Cohorts
$736,723Ingrid Bernadette Borecki · Washington University · R01 · FY2014 · DK
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$736,103David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$735,995Mandana Khalili · University Of California, San Francisco · U01 · FY2023 · DK
The Saint Louis University Component of the NASH Clinical Research Network
$735,898Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2009 · DK
Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance
$735,693Zoltan P Arany · University Of Pennsylvania · R01 · FY2025 · DK
Dietary Effects on Imaging and Fluid-based Biomarkers of the Adipose-Brain Axis in Alzheimers Disease
$735,554Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2022 · AG
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets
$735,127Peter J Havel · University Of California At Davis · R01 · FY2015 · HL
Molecular Biology of the Metastatic Phenotype
$735,103Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$734,749Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · HL
Genes and Gene Networks Associated with Obesity and Diabetes
$734,361Alan D Attie · University Of Wisconsin-Madison · R01 · FY2010 · DK
Genetic investigations of cardiometabolic disease: pleiotropy, gene x environment and causal inference analyses
$734,221Rany Salem · University Of California, San Diego · R01 · FY2024 · DK
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$734,114Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2025 · DK
Southern California Children's Enviromental Health Center (SC-CEHC)
$734,051Rob S McConnell · University Of Southern California · P01 · FY2015 · ES
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
$733,997Gerald I Shulman · Yale University · R01 · FY2018 · DK
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
$733,997Gerald I Shulman · Yale University · R01 · FY2017 · DK
Sex-Specific Risk of Metabolic and Cardiovascular Disease
$733,978John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2025 · HL
Automated quantification of lipid droplets in fatty liver tissue sections
$733,790Patrick M McDonough · Vala Sciences, Inc. · R42 · FY2011 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2023 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2021 · DK